09/27/2013    

PODIATRIC PRODUCTS IN THE NEWS

IN Podiatrist is first to Implant Cellular Allogeneic Bone Graft 

 

RTI Surgical Inc., a global surgical implant company, has announced the first implantation of the company’s map3™ Cellular Allogeneic Bone Graft implant in a foot and ankle procedure. Michael Lyons, DPM, an associate member of the American College of Foot and Ankle Surgeons, performed the implantation during a medial column fusion procedure in Indiana. He used the implant chip's allograft configuration, one of two configurations that will be available.

 

Dr. Michael Lyons

 

“Taking into account the published MAPC™ research, I decided to use map3 in a complex case with an immune-compromised patient because it would support the patient’s ability to heal,” said Dr. Lyons. 

 

Source: istockanalyst [9/25/13]